Skip to Content

WPI 3631 (Hydromorphone Hydrochloride Extended-Release 32 mg)

Pill with imprint WPI 3631 is White, Round and has been identified as Hydromorphone Hydrochloride Extended-Release 32 mg. It is supplied by Actavis Pharma, Inc..

Hydromorphone is used in the treatment of chronic pain; pain; cough; anesthetic adjunct and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Hydromorphone 32 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 3631

Hydromorphone Hydrochloride Extended-Release

Imprint:
WPI 3631
Strength:
32 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Narcotic analgesics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Labeler / Supplier:
Actavis Pharma, Inc.
National Drug Code (NDC):
00591-3631

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide